EYPT

EyePoint Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$13.40

Market Cap

$1.12B

Beta

1.79

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-27.50%

EPS Growth (YoY)-36.80%

Revenue CAGR 3Y-8.83%

P/E Ratio0.0

PEG Ratio—

FCF Yield-21.77%

Debt / Equity0.07

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for EYPT.